Is This Stock a Screaming Buy: Collegium Pharmaceutical, Inc. (NASDAQ:COLL)

Equity Research firms currently have a positive stance on shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL). The majority of analysts covering the equity have a consensus Strong Buy recommendation on the stock, yielding a score of 1.50. This is based on the research brokerage reports taken into consideration by Thomson Reuters. Those same analysts are projecting that the stock will reach $27.40 on a short term basis.

At the time of writing, the stock was trading at $18.22. This represents a change from the opening price of 1.33%. In terms of performance, year to date, the stock is -35.78%. The monthly stock performance comes in at 80.57%. For the quarter, shares are performing at 38.62%. Weekly performance analysis shows the equity at 1.85%.

In taking a look at technical levels, shares are trading 48.66% away from the 50 day simple moving average and 14.45% away from the 200 day simple moving average. Based on a recent bid, the stock is trading -40.42% away from it’s 52- week high and 121.12% away from its 52 week low. After the recent moves, investors may also look to see if the stock has entered oversold or overbought territory and could be ripe for a bounce. As of writing, Collegium Pharmaceutical, Inc.’s RSI stands at 66.97. In looking at volatility levels, the shares saw weekly volatility of 10.64% and 9.57% over the past month.

Leave a Comment